相关实验视频
Updated: May 31, 2025

07:57
A New Method for Inducing a Depression-Like Behavior in Rats
Published on: February 22, 2018
20.8K
新诊断为淋巴瘤和骨髓瘤的患者中的焦虑和抑郁症
Oreofe O Odejide1,2, Angel M Cronin1, Tamryn F Gray1
1Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA.
Blood advances
|January 22, 2025
概括
超过一半的新诊断为淋巴瘤或骨髓瘤的患者经历了显著的焦虑和抑郁. 这些心理健康挑战会对生活质量产生负面影响,强调了早期查和支持的必要性.
科学领域:
- 在瘤学瘤学.
- 精神病学是一个精神病学.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 淋巴瘤和骨髓瘤的诊断给人带来了相当大的身体和心理负担.
- 关于这些患者群体中焦虑和抑郁症的患病率的数据有限.
- 早期识别心理健康问题对于全面的患者护理至关重要.
研究的目的:
- 描述最近被诊断为淋巴瘤或骨髓瘤的成年患者焦虑和抑郁症状的流行情况.
- 识别与这些症状相关的社会人口学因素.
- 检查焦虑/抑郁症状与生活质量 (QOL) 之间的关系.
主要方法:
- 在2021年7月至2022年9月期间进行了一项调查.
- 包括200名成年患者在淋巴瘤或骨髓瘤诊断后6个月内.
- 使用医院焦虑和抑郁量表来定义临床显著症状 (得分≥8).
- 多变量分析评估了与社会人口统计学,医疗不信任,财务满意度,社会支持和QOL相关的关联.
主要成果:
- 共有200名患者参与 (74.9%的应答率).
- 超过一半 (56.2%) 报告了临床显著的焦虑和/或抑郁症状.
- 在52.0%的患者中存在焦虑症状,在27.5%的患者中存在抑郁症.
- 较低的财务满意度和更高的医疗不信任与增加的焦虑有关.
- 较低的财务满意度和较低的社会支持与较高的抑郁率有关.
- 抑郁症与较低的QOL有显著的相关性 (调整后平均差异为-22.0).
结论:
- 新诊断的淋巴瘤和骨髓瘤患者经常经历显著的焦虑和抑郁.
- 财务不满,医疗不信任和低社会支持是关键的因素.
- 这些心理健康状况大大影响患者的生活质量.
- 系统的心理健康查和及时的心理干预对于这个患者群体至关重要.
相关概念视频
Depressive Disorders: MDD and Dysthymia
50
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
50
Psychoneuroimmunology: Diabetes and Cancer
22
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
22
Stress and Mental Health
71
Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
Individuals with depression often experience challenges in both their personal and professional...
71
Anxiety: Overview
240
Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
240
Depression: Overview
211
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
211
Antidepressant Drugs: MAOIs and Other Agents
185
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
185

